| A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal Dialysis (NCT07548853) | Taisho Pharmaceutical Co., Ltd. | 2026-05-13 |
| A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis (NCT07548840) | Taisho Pharmaceutical Co., Ltd. | 2026-05-08 |
| A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders (NCT07285291) | Taisho Pharmaceutical Co., Ltd. | 2026-01-09 |
| A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment (NCT07231029) | Taisho Pharmaceutical Co., Ltd. | 2025-12-23 |
| A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis (NCT07285304) | Taisho Pharmaceutical Co., Ltd. | 2025-12-01 |
| A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects (NCT07084961) | Taisho Pharmaceutical Co., Ltd. | 2025-08-05 |
| An Open-label Pharmacokinetic Study of TS-172 in Patients on Hemodialysis (NCT06849778) | Taisho Pharmaceutical Co., Ltd. | 2025-03-22 |
| A Drug-drug Interaction Study With TS-172 in Healthy Adult Male Subjects (NCT06837142) | Taisho Pharmaceutical Co., Ltd. | 2025-03-11 |
| A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis (NCT06745531) | Taisho Pharmaceutical Co., Ltd. | 2025-01-06 |
| A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders (NCT06745518) | Taisho Pharmaceutical Co., Ltd. | 2025-01-06 |
| A Mass Balance Study of TS-172 in Healthy Adult Subjects (NCT06596356) | Taisho Pharmaceutical Co., Ltd. | 2024-09-26 |
| A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly Subjects (NCT05819710) | Taisho Pharmaceutical Co., Ltd. | 2023-05-15 |
| A Food Effect Study of TS-142 in Healthy Subjects (NCT05707897) | Taisho Pharmaceutical Co., Ltd. | 2023-02-15 |
| A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis (NCT05699239) | Taisho Pharmaceutical Co., Ltd. | 2023-02-08 |
| A Pharmacokinetic Study of TS-142 in Patients with Hepatic Impairment (NCT05624944) | Taisho Pharmaceutical Co., Ltd. | 2022-12-26 |
| Long-Term Study of TS-142 in Patients with Insomnia (NCT05461352) | Taisho Pharmaceutical Co., Ltd. | 2022-10-11 |
| Phase III Study of TS-142 in Patients with Insomnia (NCT05453136) | Taisho Pharmaceutical Co., Ltd. | 2022-08-30 |
| A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses) (NCT04979572) | Taisho Pharmaceutical Co., Ltd. | 2021-08-16 |
| A QT/QTc Evaluation Study of TS-142 in Healthy Adult Subjects (NCT04873323) | Taisho Pharmaceutical Co., Ltd. | 2021-06-07 |
| Mass Balance Study of TS-142 in Healthy Adult Subjects. (NCT04814771) | Taisho Pharmaceutical Co., Ltd. | 2021-04-19 |
| A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea. (NCT04746105) | Taisho Pharmaceutical Co., Ltd. | 2021-02-24 |
| A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects (NCT04696952) | Taisho Pharmaceutical Co., Ltd. | 2021-01-16 |
| Drug-drug Interaction Study with TS-142 in Healthy Adult Subjects (concomitant Administration of Itraconazole) (NCT04557163) | Taisho Pharmaceutical Co., Ltd. | 2020-10-13 |
| Development and Validation of a Driving Simulator for Evaluating the Residual Effects of Drugs on Driving Performance - Sensitivity Analysis Using Zopiclone As a Positive Control (NCT04108351) | Taisho Pharmaceutical Co., Ltd. | 2019-10-07 |
| An Extension Study of TS-152 in Subjects With Rheumatoid Arthritis (NCT04077567) | Taisho Pharmaceutical Co., Ltd. | 2019-10-01 |
| Safety, Pharmacokinetic, and Pharmacodynamic Study of TS-142 in Healthy Subjects (NCT04087707) | Taisho Pharmaceutical Co., Ltd. | 2019-09-17 |
| Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #3 (NCT03572985) | Taisho Pharmaceutical Co., Ltd. | 2018-06-27 |
| Safety and Efficacy of SFPP in Knee Osteoarthritis (NCT03434197) | Taisho Pharmaceutical Co., Ltd. | 2018-02-05 |
| Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #2 (NCT03413592) | Taisho Pharmaceutical Co., Ltd. | 2018-01-22 |
| A Study to Evaluate the Safety and Efficacy of TS-091 in Patients with Narcolepsy (NCT03267303) | Taisho Pharmaceutical Co., Ltd. | 2017-10-31 |
| Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #1 (NCT03278080) | Taisho Pharmaceutical Co., Ltd. | 2017-09-22 |